Ji Hyeon Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ji Hyeon Park has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Chang Hyun Kang
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea
10 shared publications - In Kyu Park
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital , Seoul 03080
10 shared publications - Samina Park
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea
10 shared publications - Young Tae Kim
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea
10 shared publications - Bubse Na
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital , Seoul 03080
9 shared publications - Hyun Joo Lee
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea
9 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (8) , e70422
Functional, Volumetric, and Growth Outcomes After Pediatric Bilateral Lung Transplantation
Objective: Long‐term multidimensional evaluations of pediatric lung transplantation are limited. This study assessed the functional recovery, volumetric adaptation, and growth in pediatric recipients by comparing age and graft type. Methods: This single‐center, retrospective, descriptive study longitudinally reviewed 16 children (age < 18 years) who underwent bilateral deceased‐donor lung transplantation. Perioperative characteristics, pulmonary function, computed tomography (CT)–derived lung volume, somatic growth, and survival were analyzed. Overall survival (OS) and chronic lung allograft dysfunction (CLAD)–free survival were estimated using the Kaplan–Meier method, and longitudinal physiological and developmental patterns were assessed descriptively. Results: In the younger group (≤ 10 years, n = 7) and the older group (> 10 years, n = 9), lobar transplantation was performed in 5 (71.4%) and 3 (33.3%) patients, respectively. CLAD was diagnosed in 1 younger recipient (14.3%) and 2 older recipients (22.2%). OS did not differ significantly between age groups (log‐rank p = 0.96), and CLAD‐free survival was comparable (log‐rank p = 0.73). CT volumetry demonstrated progressive postoperative lung expansion with similar temporal trajectories across age groups and between lobar and whole‐lung grafts. Growth patterns demonstrated meaningful postoperative improvement, with many children who exhibited faltering pretransplant growth demonstrating catch‐up toward individualized percentile curves. Conclusions: Pediatric lung transplantation results in favorable long‐term recovery, including functional improvement, durable volumetric adaptation, and partial restoration of growth dynamics. Comparable outcomes between lobar and whole‐lung grafts support the use of size‐reduced grafts in cases of donor–recipient mismatch.
- 4 August 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (8) , e70422
Open AccessFunctional, Volumetric, and Growth Outcomes After Pediatric Bilateral Lung Transplantation
Objective: Long‐term multidimensional evaluations of pediatric lung transplantation are limited. This study assessed the functional recovery, volumetric adaptation, and growth in pediatric recipients by comparing age and graft type. Methods: This single‐center, retrospective, descriptive study longitudinally reviewed 16 children (age < 18 years) who underwent bilateral deceased‐donor lung transplantation. Perioperative characteristics, pulmonary function, computed tomography (CT)–derived lung volume, somatic growth, and survival were analyzed. Overall survival (OS) and chronic lung allograft dysfunction (CLAD)–free survival were estimated using the Kaplan–Meier method, and longitudinal physiological and developmental patterns were assessed descriptively. Results: In the younger group (≤ 10 years, n = 7) and the older group (> 10 years, n = 9), lobar transplantation was performed in 5 (71.4%) and 3 (33.3%) patients, respectively. CLAD was diagnosed in 1 younger recipient (14.3%) and 2 older recipients (22.2%). OS did not differ significantly between age groups (log‐rank p = 0.96), and CLAD‐free survival was comparable (log‐rank p = 0.73). CT volumetry demonstrated progressive postoperative lung expansion with similar temporal trajectories across age groups and between lobar and whole‐lung grafts. Growth patterns demonstrated meaningful postoperative improvement, with many children who exhibited faltering pretransplant growth demonstrating catch‐up toward individualized percentile curves. Conclusions: Pediatric lung transplantation results in favorable long‐term recovery, including functional improvement, durable volumetric adaptation, and partial restoration of growth dynamics. Comparable outcomes between lobar and whole‐lung grafts support the use of size‐reduced grafts in cases of donor–recipient mismatch.
- Open Access
- 1 July 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (7)
Long-Term Outcomes of Indocyanine Green Versus Inflation-Deflation for Intersegmental Plane Identification in Segmentectomy for Early-Stage Lung Cancer
Objectives: This study aimed to evaluate whether the method of intersegmental plane (ISP) identification—indocyanine green (ICG) fluorescence vs the conventional inflation-deflation (ID) technique—affects resection margin adequacy, oncologic outcomes, or postoperative pulmonary function after anatomical segmentectomy for early-stage non–small-cell lung cancer (NSCLC). Methods: We retrospectively analysed 410 patients who underwent segmentectomy for clinical N0M0 NSCLC between January 2018 and December 2023. The ISP was identified using the ID and ICG methods in 286 and 124 patients, respectively. Perioperative, pathologic, and survival outcomes were compared before and after inverse probability of treatment weighting (IPTW). Results: Operative time and hospital stay were slightly shorter in the ICG than in the ID group (108.0 vs 115.0 min, P = .031; 4.0 vs 5.0 days, P = .003), whereas postoperative complication rates and pulmonary function changes were comparable. Central resection margins were longer in the ID group (2.5 vs 2.0 cm, P = .014), whereas lateral margin distances did not differ significantly. Recurrence-free and overall survival were similar between the 2 groups (log-rank P = .97 and P = .18). In IPTW-adjusted multivariable Cox analysis, the ISP identification method was not associated with recurrence or survival. Conclusions: The ISP identification method was not associated with differences in functional or oncologic outcomes after anatomical segmentectomy. These findings suggest that the choice of technique may be guided by surgeon preference and technical considerations.
- 1 July 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (7)
Open AccessLong-Term Outcomes of Indocyanine Green Versus Inflation-Deflation for Intersegmental Plane Identification in Segmentectomy for Early-Stage Lung Cancer
Objectives: This study aimed to evaluate whether the method of intersegmental plane (ISP) identification—indocyanine green (ICG) fluorescence vs the conventional inflation-deflation (ID) technique—affects resection margin adequacy, oncologic outcomes, or postoperative pulmonary function after anatomical segmentectomy for early-stage non–small-cell lung cancer (NSCLC). Methods: We retrospectively analysed 410 patients who underwent segmentectomy for clinical N0M0 NSCLC between January 2018 and December 2023. The ISP was identified using the ID and ICG methods in 286 and 124 patients, respectively. Perioperative, pathologic, and survival outcomes were compared before and after inverse probability of treatment weighting (IPTW). Results: Operative time and hospital stay were slightly shorter in the ICG than in the ID group (108.0 vs 115.0 min, P = .031; 4.0 vs 5.0 days, P = .003), whereas postoperative complication rates and pulmonary function changes were comparable. Central resection margins were longer in the ID group (2.5 vs 2.0 cm, P = .014), whereas lateral margin distances did not differ significantly. Recurrence-free and overall survival were similar between the 2 groups (log-rank P = .97 and P = .18). In IPTW-adjusted multivariable Cox analysis, the ISP identification method was not associated with recurrence or survival. Conclusions: The ISP identification method was not associated with differences in functional or oncologic outcomes after anatomical segmentectomy. These findings suggest that the choice of technique may be guided by surgeon preference and technical considerations.
- 1 December 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (12)
Volumetric Compensation After Anatomical Lung Resection: Comparative Analysis of Lobectomy and Segmentectomy
Objectives: To compare postoperative lung function and volume compensation in lung cancer patients after lobectomy or segmentectomy. Methods: We retrospectively reviewed patients who underwent initial lung cancer surgery between 2019 and 2021. Of 1076 patients, 870 underwent lobectomy and 206 segmentectomy. Propensity score matching (PSM) of 1:2 was performed using age, sex, smoking status, and preoperative pulmonary function tests (PFTs). Total lung volume (TLV) was calculated using deep learning-assisted 3D lung segmentation on thin-section computed tomography images. Postoperative lung volumes were compared with predicted postoperative (PPO) volumes and correlated with PFT results. Results: After matching, 378 lobectomy and 189 segmentectomy patients were included. TLV reduction was similar between groups, but contralateral lung volume (CLV) increased more after lobectomy (P = .010). Diffusing capacity of the lung for carbon monoxide was better preserved after segmentectomy (P = .029), whereas force vital capacity and forced expiratory volume in 1 second (FEV1) were similar. Actual postoperative PFT values exceeded predicted values in both groups, but the discrepancy was larger after lobectomy (P < .001). In segmentectomy, single-segment resection showed no compensation, while multiple-segment resections had variable compensation patterns. Ipsilateral lung volume changes contributed more than CLV changes, and compensation patterns varied by lobe. The TLV change correlated with forced vital capacity and FEV1 but not diffusing capacity of the lung for carbon monoxide. Conclusions: Lobectomy induced greater CLV compensation than segmentectomy. Although overall lung function preservation was similar, lobectomy resulted in a greater difference between actual and PPO pulmonary function.
- 1 December 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (12)
Volumetric Compensation After Anatomical Lung Resection: Comparative Analysis of Lobectomy and Segmentectomy
Objectives: To compare postoperative lung function and volume compensation in lung cancer patients after lobectomy or segmentectomy. Methods: We retrospectively reviewed patients who underwent initial lung cancer surgery between 2019 and 2021. Of 1076 patients, 870 underwent lobectomy and 206 segmentectomy. Propensity score matching (PSM) of 1:2 was performed using age, sex, smoking status, and preoperative pulmonary function tests (PFTs). Total lung volume (TLV) was calculated using deep learning-assisted 3D lung segmentation on thin-section computed tomography images. Postoperative lung volumes were compared with predicted postoperative (PPO) volumes and correlated with PFT results. Results: After matching, 378 lobectomy and 189 segmentectomy patients were included. TLV reduction was similar between groups, but contralateral lung volume (CLV) increased more after lobectomy (P = .010). Diffusing capacity of the lung for carbon monoxide was better preserved after segmentectomy (P = .029), whereas force vital capacity and forced expiratory volume in 1 second (FEV1) were similar. Actual postoperative PFT values exceeded predicted values in both groups, but the discrepancy was larger after lobectomy (P < .001). In segmentectomy, single-segment resection showed no compensation, while multiple-segment resections had variable compensation patterns. Ipsilateral lung volume changes contributed more than CLV changes, and compensation patterns varied by lobe. The TLV change correlated with forced vital capacity and FEV1 but not diffusing capacity of the lung for carbon monoxide. Conclusions: Lobectomy induced greater CLV compensation than segmentectomy. Although overall lung function preservation was similar, lobectomy resulted in a greater difference between actual and PPO pulmonary function.
- Open Access
- 1 November 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (11) , 9375-9387
Long-term clinical outcomes of mediastinal lymphoma after surgical resection: reassessing the role of surgery
Background: Standard treatment regimens for lymphoma typically involve chemotherapy, often combined with radiation therapy, tailored to the disease’s stage and subtype. This study aimed to assess the long-term clinical outcomes of surgical resection of primary mediastinal lymphoma and evaluate the surgery’s therapeutic role. Methods: From March 2008 to April 2023, 31 patients at our institution underwent surgery for mediastinal lymphoma, with 26 qualifying for this study after excluding diagnostic-only surgeries. We analyzed early outcomes and overall survival and identified risk factors using Cox regression analysis. Results: Primary operations were performed on 18 patients, while eight underwent salvage operations. There was no operation-related mortality, although two cases had complications. The 5-year overall survival rate was 85.9%, with 100% in the primary and 60% in the salvage operation groups. Subgroup analysis revealed a significantly higher 5-year overall survival rate for complete (R0) resections compared to incomplete resections (94.7% vs. 33.3%, P=0.003). Univariable analysis identified salvage operations [hazard ratio (HR) =14.84, P=0.02], pericardial resection (HR =13.42, P=0.03), and incomplete resection (HR =15.75, P=0.03) as significant risk factors for long-term mortality. Multivariable analysis showed that pericardial resection (HR =13.53, P=0.04) and adjuvant radiotherapy (HR =25.58, P=0.04) were significant risk factors for recurrence. Conclusions: Surgical resection shows promising long-term outcomes for mediastinal lymphoma, particularly for incidentally detected or completely resected tumors. However, the decisions for salvage surgery should be made cautiously, considering the highly selected patient group and employing a multidisciplinary approach.
- 1 November 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (11) , 9375-9387
Open AccessLong-term clinical outcomes of mediastinal lymphoma after surgical resection: reassessing the role of surgery
Background: Standard treatment regimens for lymphoma typically involve chemotherapy, often combined with radiation therapy, tailored to the disease’s stage and subtype. This study aimed to assess the long-term clinical outcomes of surgical resection of primary mediastinal lymphoma and evaluate the surgery’s therapeutic role. Methods: From March 2008 to April 2023, 31 patients at our institution underwent surgery for mediastinal lymphoma, with 26 qualifying for this study after excluding diagnostic-only surgeries. We analyzed early outcomes and overall survival and identified risk factors using Cox regression analysis. Results: Primary operations were performed on 18 patients, while eight underwent salvage operations. There was no operation-related mortality, although two cases had complications. The 5-year overall survival rate was 85.9%, with 100% in the primary and 60% in the salvage operation groups. Subgroup analysis revealed a significantly higher 5-year overall survival rate for complete (R0) resections compared to incomplete resections (94.7% vs. 33.3%, P=0.003). Univariable analysis identified salvage operations [hazard ratio (HR) =14.84, P=0.02], pericardial resection (HR =13.42, P=0.03), and incomplete resection (HR =15.75, P=0.03) as significant risk factors for long-term mortality. Multivariable analysis showed that pericardial resection (HR =13.53, P=0.04) and adjuvant radiotherapy (HR =25.58, P=0.04) were significant risk factors for recurrence. Conclusions: Surgical resection shows promising long-term outcomes for mediastinal lymphoma, particularly for incidentally detected or completely resected tumors. However, the decisions for salvage surgery should be made cautiously, considering the highly selected patient group and employing a multidisciplinary approach.
- Open Access
- 1 October 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 7838-7852
Impact of sarcopenia on early surgical outcomes in elderly patients following lung cancer surgery: a prospective cohort study
Background: Sarcopenia, characterized by reduced muscle mass, strength, and physical performance, has been linked to poor surgical outcomes. Its prevalence increases markedly with age and has been associated with various adverse health conditions in the elderly, including mental health issues like cognitive impairment, quality of life and depression. However, its impact based on international criteria remains unclear in elderly patients undergoing lung cancer surgery. Therefore, we aimed to prospectively evaluate the association between sarcopenia, defined by international guidelines, and postoperative outcomes, as well as geriatric mental health, in this population. Methods: The LUng CAncer Surgery in sarcoPENia patients with old age (LUCAS-PEN) study (ClinicalTrials.gov identifier NCT05346185) prospectively enrolled patients aged ≥70 years undergoing curative lung cancer surgery. Sarcopenia was defined using the Asian Working Group for Sarcopenia (AWGS) criteria. The primary outcome was postoperative complication rates. Propensity score matching (PSM, 1:4) was performed to reduce selection bias. Geriatric mental health was assessed using the Korean version of the Geriatric Depression Scale (GDS-K), the Korean version of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L), EuroQoL Visual Analog Scale (EQ-VAS), and the Korean version of the Montreal Cognitive Assessment (K-MoCA). Results: Among 400 patients, 357 completed all assessments, and 24 (6.7%) were diagnosed with sarcopenia. Compared to non-sarcopenic patients, the sarcopenia group had a lower body mass index (22.73±2.63 vs. 23.29±2.87 kg/m2, P=0.38) and a higher proportion of clinical node (N) stage ≥1 (29.2% vs. 18.8%, P=0.40). Overall complication rates (25.0% vs. 21.6%, P=0.80) did not significantly differ. In multivariable analysis, neither sarcopenia nor its components were associated with postoperative complications. After PSM, complication rates remained similar between sarcopenic and non-sarcopenic groups (24.0% vs. 25.0%, P>0.99). However, the sarcopenia group had significantly worse mental health outcomes: higher GDS-K scores (6.5 vs. 3.0, P=0.001), lower EQ-5D-5L (0.829 vs. 0.728, Pvs. 70, P=0.002), and a higher prevalence of cognitive impairment (27.8% vs. 7.2%, P=0.01). Conclusions: This is the first large prospective study to evaluate sarcopenia according to international guidelines for lung cancer surgery. In this prospective study applying AWGS criteria, sarcopenia was not associated with increased early postoperative complications in elderly patients undergoing lung cancer surgery. However, sarcopenia was linked to poorer mental health.
- 1 October 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 7838-7852
Open AccessImpact of sarcopenia on early surgical outcomes in elderly patients following lung cancer surgery: a prospective cohort study
Background: Sarcopenia, characterized by reduced muscle mass, strength, and physical performance, has been linked to poor surgical outcomes. Its prevalence increases markedly with age and has been associated with various adverse health conditions in the elderly, including mental health issues like cognitive impairment, quality of life and depression. However, its impact based on international criteria remains unclear in elderly patients undergoing lung cancer surgery. Therefore, we aimed to prospectively evaluate the association between sarcopenia, defined by international guidelines, and postoperative outcomes, as well as geriatric mental health, in this population. Methods: The LUng CAncer Surgery in sarcoPENia patients with old age (LUCAS-PEN) study (ClinicalTrials.gov identifier NCT05346185) prospectively enrolled patients aged ≥70 years undergoing curative lung cancer surgery. Sarcopenia was defined using the Asian Working Group for Sarcopenia (AWGS) criteria. The primary outcome was postoperative complication rates. Propensity score matching (PSM, 1:4) was performed to reduce selection bias. Geriatric mental health was assessed using the Korean version of the Geriatric Depression Scale (GDS-K), the Korean version of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L), EuroQoL Visual Analog Scale (EQ-VAS), and the Korean version of the Montreal Cognitive Assessment (K-MoCA). Results: Among 400 patients, 357 completed all assessments, and 24 (6.7%) were diagnosed with sarcopenia. Compared to non-sarcopenic patients, the sarcopenia group had a lower body mass index (22.73±2.63 vs. 23.29±2.87 kg/m2, P=0.38) and a higher proportion of clinical node (N) stage ≥1 (29.2% vs. 18.8%, P=0.40). Overall complication rates (25.0% vs. 21.6%, P=0.80) did not significantly differ. In multivariable analysis, neither sarcopenia nor its components were associated with postoperative complications. After PSM, complication rates remained similar between sarcopenic and non-sarcopenic groups (24.0% vs. 25.0%, P>0.99). However, the sarcopenia group had significantly worse mental health outcomes: higher GDS-K scores (6.5 vs. 3.0, P=0.001), lower EQ-5D-5L (0.829 vs. 0.728, Pvs. 70, P=0.002), and a higher prevalence of cognitive impairment (27.8% vs. 7.2%, P=0.01). Conclusions: This is the first large prospective study to evaluate sarcopenia according to international guidelines for lung cancer surgery. In this prospective study applying AWGS criteria, sarcopenia was not associated with increased early postoperative complications in elderly patients undergoing lung cancer surgery. However, sarcopenia was linked to poorer mental health.
- Open Access
- 1 October 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 8300-8312
The impact of preoperative percutaneous transthoracic needle biopsy on pleural recurrence in clinically early-stage non-small cell lung cancer
Background: The potential association between preoperative percutaneous transthoracic needle biopsy (PTNB) and pleural recurrence in lung cancer remains controversial. This study aimed to determine whether PTNB increases the risk of pleural recurrence in patients with clinically diagnosed stage I non-small cell lung cancer (NSCLC). Methods: We retrospectively analyzed 1,733 patients with clinical stage I NSCLC who underwent surgical resection between January 2018 and December 2020. Patients were divided into the PTNB group (n=699) and the non-PTNB group (n=1,034). After 1:1 propensity score matching (PSM), risk factors for pleural recurrence were assessed using Fine-Gray subdistribution hazard models. Cumulative incidence rate and overall survival (OS) were also analyzed. Results: After matching, 530 patients were included in each group. Multivariate Fine-Gray analysis revealed that PTNB [subdistribution hazard ratio (sHR) =3.74; 95% confidence interval (CI): 1.06–13.20; P=0.040] and visceral pleural invasion (VPI) (sHR =3.12; 95% CI: 1.10–8.90; P=0.03) were independent risk factors for isolated pleural recurrence, whereas lymphatic invasion was not (sHR =2.32; 95% CI: 0.82–6.56; P=0.11). For all types of recurrence, PTNB, VPI, and lymphatic invasion were significant predictors (all PConclusions: Preoperative PTNB was statistically correlated with an increased pleural recurrence in clinical stage I NSCLC, even among patients without conventional high-risk pathological features. Careful consideration is warranted when deciding on PTNB for early-stage disease.
- 1 October 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 8300-8312
Open AccessThe impact of preoperative percutaneous transthoracic needle biopsy on pleural recurrence in clinically early-stage non-small cell lung cancer
Background: The potential association between preoperative percutaneous transthoracic needle biopsy (PTNB) and pleural recurrence in lung cancer remains controversial. This study aimed to determine whether PTNB increases the risk of pleural recurrence in patients with clinically diagnosed stage I non-small cell lung cancer (NSCLC). Methods: We retrospectively analyzed 1,733 patients with clinical stage I NSCLC who underwent surgical resection between January 2018 and December 2020. Patients were divided into the PTNB group (n=699) and the non-PTNB group (n=1,034). After 1:1 propensity score matching (PSM), risk factors for pleural recurrence were assessed using Fine-Gray subdistribution hazard models. Cumulative incidence rate and overall survival (OS) were also analyzed. Results: After matching, 530 patients were included in each group. Multivariate Fine-Gray analysis revealed that PTNB [subdistribution hazard ratio (sHR) =3.74; 95% confidence interval (CI): 1.06–13.20; P=0.040] and visceral pleural invasion (VPI) (sHR =3.12; 95% CI: 1.10–8.90; P=0.03) were independent risk factors for isolated pleural recurrence, whereas lymphatic invasion was not (sHR =2.32; 95% CI: 0.82–6.56; P=0.11). For all types of recurrence, PTNB, VPI, and lymphatic invasion were significant predictors (all PConclusions: Preoperative PTNB was statistically correlated with an increased pleural recurrence in clinical stage I NSCLC, even among patients without conventional high-risk pathological features. Careful consideration is warranted when deciding on PTNB for early-stage disease.
- Open Access
- 23 April 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 57 (5) , 450-457
Comparative Study of Indocyanine Green Intravenous Injection and the Inflation-Deflation Method for Assessing Resection Margins in Segmentectomy for Lung Cancer: A Single-Center Retrospective Study
Seon Yong Bae, M.D., Taeyoung Yun, M.D., Ji Hyeon Park, M.D., Bubse Na, M.D., Kwon Joong Na, M.D., Samina Park, M.D., Hyun Joo Lee, M.D., Ph.D., In Kyu Park, M.D., Ph.D., Chang Hyun Kang, M.D., Ph.D., Young Tae Kim, M.D., Ph.D.. J Chest Surg 2024;57:450-7. https://doi.org/10.5090/jcs.24.008
- 23 April 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 57 (5) , 450-457
Open AccessComparative Study of Indocyanine Green Intravenous Injection and the Inflation-Deflation Method for Assessing Resection Margins in Segmentectomy for Lung Cancer: A Single-Center Retrospective Study
Seon Yong Bae, M.D., Taeyoung Yun, M.D., Ji Hyeon Park, M.D., Bubse Na, M.D., Kwon Joong Na, M.D., Samina Park, M.D., Hyun Joo Lee, M.D., Ph.D., In Kyu Park, M.D., Ph.D., Chang Hyun Kang, M.D., Ph.D., Young Tae Kim, M.D., Ph.D.. J Chest Surg 2024;57:450-7. https://doi.org/10.5090/jcs.24.008
- Open Access
- 13 March 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 57 (4) , 342-350
Safety of Perioperative Maintenance of Antiplatelet Agents in Elderly Patients Undergoing Lung Cancer Surgery
Hee Ju Hong, M.D., Ji Hyeon Park, M.D., Samina Park, M.D., In Kyu Park, M.D., Ph.D., Chang Hyun Kang, M.D., Ph.D., Young Tae Kim, M.D., Ph.D.. J Chest Surg 2024;57:342-50. https://doi.org/10.5090/jcs.23.155
- 13 March 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 57 (4) , 342-350
Open AccessSafety of Perioperative Maintenance of Antiplatelet Agents in Elderly Patients Undergoing Lung Cancer Surgery
Hee Ju Hong, M.D., Ji Hyeon Park, M.D., Samina Park, M.D., In Kyu Park, M.D., Ph.D., Chang Hyun Kang, M.D., Ph.D., Young Tae Kim, M.D., Ph.D.. J Chest Surg 2024;57:342-50. https://doi.org/10.5090/jcs.23.155
- Open Access
- 1 January 2024
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2024 (1)
Enhancing Medication History Accuracy in a Tertiary Hospital: Pharmacist‐Led Counseling With Nationwide Medication History Sharing Program Versus Conventional Methods
Aims: Medication discrepancies during transitions of care pose substantial risks, particularly in older patients receiving complex medication regimens. Obtaining the best possible medication history (BPMH) is crucial to minimize this risk. This study aimed to evaluate the effectiveness of a pharmacist‐led BPMH using various information sources including a nationwide medication history sharing program compared to conventional interviews in a tertiary hospital setting. In addition, we identified factors contributing to medication inaccuracies.Methods: A single‐center prospective study involving older patients scheduled for thoracic surgery at a tertiary hospital was conducted. Medication histories obtained through conventional interviews during the initial assessment on admission were compared with those obtained through BPMH by pharmacist‐led interviews. Logistic regression analysis was used to identify factors associated with medication inaccuracies.Results: This study included 216 patients, a significant proportion of whom were experiencing polypharmacy. The pharmacist‐led BPMH approach demonstrated superior accuracy in documenting medication histories, with conventional methods showing inaccuracies in over 70% of the cases. Factors that significantly increased the likelihood of inaccuracies included the number of medications and number of prescribers. Nonoral and as‐needed medications are particularly prone to inaccuracies.Conclusions: Pharmacist‐led BPMH significantly improved medication history accuracy compared to conventional methods, which had inaccuracies in over 70%. It is important to be careful when obtaining BPMH for older adults, particularly those with complex medication regimens, nonoral medications, or PRN medications, to enhance patient safety and reduce medication‐related risks.Trial Registration: Clinical Trial Registry identifier: KCT-006813.
- 1 January 2024
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2024 (1)
Open AccessEnhancing Medication History Accuracy in a Tertiary Hospital: Pharmacist‐Led Counseling With Nationwide Medication History Sharing Program Versus Conventional Methods
Aims: Medication discrepancies during transitions of care pose substantial risks, particularly in older patients receiving complex medication regimens. Obtaining the best possible medication history (BPMH) is crucial to minimize this risk. This study aimed to evaluate the effectiveness of a pharmacist‐led BPMH using various information sources including a nationwide medication history sharing program compared to conventional interviews in a tertiary hospital setting. In addition, we identified factors contributing to medication inaccuracies.Methods: A single‐center prospective study involving older patients scheduled for thoracic surgery at a tertiary hospital was conducted. Medication histories obtained through conventional interviews during the initial assessment on admission were compared with those obtained through BPMH by pharmacist‐led interviews. Logistic regression analysis was used to identify factors associated with medication inaccuracies.Results: This study included 216 patients, a significant proportion of whom were experiencing polypharmacy. The pharmacist‐led BPMH approach demonstrated superior accuracy in documenting medication histories, with conventional methods showing inaccuracies in over 70% of the cases. Factors that significantly increased the likelihood of inaccuracies included the number of medications and number of prescribers. Nonoral and as‐needed medications are particularly prone to inaccuracies.Conclusions: Pharmacist‐led BPMH significantly improved medication history accuracy compared to conventional methods, which had inaccuracies in over 70%. It is important to be careful when obtaining BPMH for older adults, particularly those with complex medication regimens, nonoral medications, or PRN medications, to enhance patient safety and reduce medication‐related risks.Trial Registration: Clinical Trial Registry identifier: KCT-006813.